Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir to Treat HCV Genotype 1-6 Infection in Patients Without Cirrhosis Including HIV Co-Infection
Volume
112
Pagination
S490 - S490
DOI
10.14309/00000434-201710001-00869
ISSN
0002-9270
Metadata
Show full item recordAuthors
Bernstein, DE; Foster, G; Dylla, D; Mauss, S; Nelson, D; Asselah, T; Flamm, S; Cooper, C; Liu, R; Viani, RCollections
- Centre for Immunobiology [1121]